Typ : |
tidningen |
|
forskargrupper : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Författare : |
Ensom MHH, Decarie D, Sheppard I. |
Titel : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Hänvisningar : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Evidensgrad : |
|
fysikalisk stabilitet : |
|
kemisk stabilitet : |
|
andra metoder : |
|
Kommentarer : |
|
Förteckning över substanser
Lansoprazole
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
Natriumhydroxid |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
4°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
Natriumhydroxid |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
|
91 |
|
|
|
|
|